知镜 Cognispect · 医学文献与研究工作台

Diagnostic accuracy and safety of epicutaneous testing in fixed drug eruption.

de Oliveira FB, Cheuiche AV, Tejada GL, Bonamigo RR.
Anais brasileiros de dermatologia · 2026-11-12 · PMID 43019620

文献摘要

Background Fixed Drug Eruption (FDE) is a delayed drug reaction in which Oral Provocation Testing (OPT) remains the diagnostic gold standard despite safety and ethical concerns. Skin tests, including Patch Test (PT) and the Repeated Open Application Test (ROAT), may be safer alternatives, but their diagnostic accuracy remains uncertain. Objectives To evaluate the diagnostic accuracy and safety of patch testing and ROAT, as complementary tools to OPT, for identifying the culprit drug in FDE. Methods Systematic review and meta-analysis followed PRISMA-DTA/2020 guidelines and the PIRD framework. Five databases (MEDLINE, Embase, LILACS, Scopus, and Web of Science) were searched from 1972 to October 2025. Quality was assessed via QUADAS-2 for studies in quantitative synthesis. A bivariate Bayesian random-effects model estimated pooled sensitivity and specificity and generated the Summary Receiver Operating Characteristic (SROC) plot. Results Seventy-eight studies were included in the qualitative synthesis, comprising 225 paired diagnostic interventions in 145 patients; 25 studies provided data for meta-analysis. Patch testing showed low pooled sensitivity (0.220; 95% CrI 0.060-0.441) and high specificity (0.964; 95% CrI 0.898-0.992), with positive and negative likelihood ratios of 5.98 and 0.81, respectively. Performance was higher on lesional than non-lesional skin (19.2% vs. 5.0%; OR = 7.05, 95% CI 2.03-24.39) and varied by drug class. Safety was favorable, with local reactivation in 2.9% of PT and one systemic reaction. Study limitations Evidence was limited by small, mostly descriptive studies, scarce negative controls, absence of immunosuppressed patients in the accuracy dataset, and imprecise ROAT specificity estimates. Conclusion Patch testing and ROAT may aid FDE investigation, particularly when applied to lesional skin, but their low sensitivity limits their rule-out value. They should complement, not replace, OPT until standardized prospective evidence is available. Standardized prospective studies are needed.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。